Ludvigsen, M., Kamper, P., Hamilton-Dutoit, S. J., Bendix, K., Møller, M. B.
, d'Amore, F. A. & Honoré, B. (2015).
Relationship of intratumoural protein expression patterns to age and Epstein-Barr virus status in classical Hodgkin lymphoma.
European Journal of Haematology,
95(2), 137-149.
https://doi.org/10.1111/ejh.12463
Christensen, B., Ludvigsen, M., Nellemann, B., Kopchick, J. J.
, Honoré, B. & Jørgensen, J. O. L. (2015).
Serum Proteomic Changes after Randomized Prolonged Erythropoietin Treatment and/or Endurance Training: Detection of Novel Biomarkers.
PLoS One,
10(2), e0117119.
https://doi.org/10.1371/journal.pone.0117119
Andersen, M. D.
, Nielsen, P. S., Bendix, K., Riber-Hansen, R., Steiniche, T., Hamilton-Dutoit, S., Clausen, M. & d'Amore, F. (2015).
Tumour-associated mast cells in classical Hodgkin's lymphoma: correlation with histological subtype, other tumour-infiltrating inflammatory cell subsets and outcome.
European Journal of Haematology, 252-259.
https://doi.org/10.1111/ejh.12583
Christensen, M. S., Hansen, J.
, Ramlau-Hansen, C., Toft, G., d'Amore, F. & Kolstad, H. A. (2014).
0177 Exposure to styrene and the risk of cancer: a long-term follow-up study of workers in the Danish reinforced plastics industry.
Occupational & Environmental Medicine,
71 Suppl 1, A82-3.
https://doi.org/10.1136/oemed-2014-102362.257
Zinzani, P., Coiffier, B., Radford, J., Caballero, D., Fields, P., Chamuleau, M.
, D'Amore, F. A., Haioun, C., Thieblemont, C., Barca, E., Garcia, C., Johnson, PW., Van Imhoff, G., Saunders, A., Dwyer, K. & Morschhauser, F. (2014).
A phase II open-label, multi-center study of anti-CCR4 monoclonal antibody mogamulizumab (KW-0761) in patients with previously treated peripheral t-cell lymphoma (PTCL).
Blood,
124(21).
Gisselbrecht, C., Borchmann, P.
, D'Amore, F., Illidge, T. M. & Zinzani, P. L. (2014).
Challenging CD30-positive lymphomas--current challenges, new insights and future directions: joining a conversation on CD30+ lymphomas.
Leukemia Research,
38(9), 1003.
https://doi.org/10.1016/j.leukres.2014.08.013
O'Connor, O. A., Bhagat, G., Ganapathi, K.
, Pedersen, M. B., D'Amore, F., Radeski, D. & Bates, S. E. (2014).
Changing the paradigms of treatment in peripheral T-cell lymphoma: from biology to clinical practice.
Clinical Cancer Research,
20(20), 5240-54. Article e006363.
https://doi.org/10.1158/1078-0432.CCR-14-2020
Madsen, C., Pedersen, M. B., Vase, M. Ø., Segel, E.
, Bendix, K., Jensen, B. A., Jensen, P., Møller, M. B., Johansen, P., Munksgaard, L., Brown, P. D. N.
& D'Amore, F. A. (2014).
Clinical outcome determinats for sequentially transformed indolent lymphomas treated with or without autologous stem cell transplantation.
Blood,
124(21).
Gormsen, L. C., Wassberg, C., Molin, D., Kamper, P. M. H., Enblad, G.
& D'Amore, F. A. (2014).
Diffusely increased bone marrow 18F-FDG uptake is an independent predictor of focal bone lesions in patients with newly diagnosed classical Hodgkin Lymphoma.
Blood,
124(21).
Pedersen, M. B., Riber-Hansen, R., Nielsen, P. S., Bendix, K., Hamilton-Dutoit, S. J., D'Amore, F. & Steiniche, T. (2014).
Digital pathology for the validation of tissue microarrays in peripheral T-cell lymphomas.
Applied Immunohistochemistry & Molecular Morphology,
22(8), 577-84.
https://doi.org/10.1097/PAI.0b013e3182a7d16d
Pedersen, M. B., Hamilton-Dutoit, S. J., Bendix, K., Møller, M. B., Nørgaard, P., Johansen, P., Ralfkiaer, E., Brown, P. D. N., Hansen, P. B., Jensen, B. A., Madsen, J., Schöllkopf, C.
& d'Amore, F. (2014).
Evaluation of clinical trial eligibility and prognostic indices in a population-based cohort of systemic peripheral T-cell lymphomas from the Danish Lymphoma Registry.
Hematological Oncology (Online),
33(4), 120-128.
https://doi.org/10.1002/hon.2153
Christensen, M. H., Hansen, J., Ramlau-Hansen, C., Toft, G.
, D'Amore, F. A. & Kolstad, H. (2014).
Exposure to styrene and the risk of cancer: a long-term follow-up study of workers in the Danish reinforced plastics industry. Occupational & Environmental Medicine,
71(Suppl 1).
Kelsen, J., Dige, A., Christensen, M.
, D'Amore, F. & Iversen, L. (2014).
Frequency and clonality of peripheral γδ T cells in psoriasis patients receiving anti-TNF-α therapy.
Clinical and Experimental Immunology,
177(1), 142–148.
https://doi.org/10.1111/cei.12331
Petruskevicius, I., Ludvigsen, M., Kamper, P., Hjortebjerg, R., Sørensen, B. S., Nielsen, B., Honoré, B. & d'Amore, F. A. (2014).
Galectin-1 as a novel biomarker in haematologic malignancies treated with non-myeloablative haematopoietic stem cell transplantation.
Petruskevicius, I.
, Ludvigsen, M., Kamper, P. M. H.
, Hjortebjerg, R., Sørensen, B. S., Nielsen, B., Honoré, B.
& D'Amore, F. A. (2014).
Galectin-1 as a novel prognostic biomarker in haematologic malignancies treated with non-myeloablative haemopoietic stem cell transplantation.. Poster session presented at European Group for Blood and Marrow Transplantation Annual Meeting, Milano, Italy.
Pedersen, M. B., Hamilton-Dutoit, S. J., Bendix, K., Noerregaard, P., Moeller, MB.
, Steiniche, T. & D'Amore, F. A. (2014).
High intratumoral macrophage content is an adverse prognostic feature in anaplastic large cell lymphoma.
Histopathology,
65(4), 490–500.
https://doi.org/10.1111/his.12407
Pedersen, M. B., Hamilton-Dutoit, S. J., Bendix, K., Nørgaard, P., Møller, M. B., Raffeld, M., Pittaluga, S.
, Steiniche, T., Bergmann, A., Vater, I., Siebert, R., Chan, W.-C.
& D'Amore, F. A. (2014).
Identification of a subset of peripheral T-cell lymphoma, not otherwise specified, characterized by FOXP3-positive regulatory T-cell phenotype, HTLV-1 negativity and poor outcome.
Blood,
124(21).
Pedersen, M. B., Hamilton-Dutoit, S. J., Bendix, K., Møller, M. B., Raffeld, M., Pittaluga, S.
, Steiniche, T., Bergmann, A., Vater, I., Siebert, R., Chan, W. C.
& D'Amore, F. A. (2014).
Identification of a subset of perpheral T-cell lymphoma, not otherwise specified, characterized by FOXP3-positive regulatory T-cell phenotype, HTLV-1 negativity and poor outcome. Identification of a subset of perpheral T-cell lymphoma, not otherwise specified, characterized by FOXP3-positive regulatory T-cell phenotype, HTLV-1 negativity and poor outcome. .
Blood,
124(21), Article 124.
Kilpivaara, O., Ristolainen, H.
, Kamper, P., Taskinen, M., Saarinen, S., Leppä, S.
, D'Amore, F. A. & Lauri, A. A. (2014).
Identification of novel germline variants in early-onset familial classical Hodgkin lymphoma with exome sequencing.
Blood,
121(24).
D'Amore, F. A., Jørgensen, J. M., Sillesen, I. B., Segel, E., Bentzen, H. H. N., Thorsgaard, M., Pulcynski, E., Pedersen, B., Gillstrom, D.
, Clausen, M. R., Kamper, P., Silkjær, T., Gormsen, L. C., Leppä, S.
& Toldbod, H. (2014).
Preliminary clinical experience on the efficacy and feasibility of a new combination regimen consisting of pixantrone, etoposide and bendamustine with or without the addition of rituximab in patients with relapsed/refractory aggressive non-hodgkin lymphomas.
Blood,
124(21).
Ludvigsen, M., Pedersen, M. B., Poulsen, T. S.
, Hamilton-Dutoit, S. J., Besenbacher, S.
, Bendix, K., Møller, M. B.
, D'Amore, F. A. & Honoré, B. (2014).
Proteomic Analysis Identifies Outcome-Predictive Clusters in Patients with Peripheral T-Cell Lymphoma, Not otherwise specified: Proteomic Analysis Identifies Outcome-Predictive Clusters in Patients with Peripheral T-Cell Lymphoma, Not otherwise specified.
Blood,
124(21), Article 124.
Abrahamsson, A., Albertsson-Lindblad, A., Brown, P. N., Baumgartner-Wennerholm, S., Pedersen, L. M.
, D'Amore, F., Nilsson-Ehle, H.
, Jensen, P., Pedersen, M., Geisler, C. H. & Jerkeman, M. (2014).
Real world data on primary treatment for mantle cell lymphoma: a Nordic Lymphoma Group observational study.
Blood,
124(8), 1288-95.
https://doi.org/10.1182/blood-2014-03-559930
El-Galaly, T., Mylam, K. J., Bøgsted, M., Brown, P., Rossing, M., Gang, A. O.
, Haglund, A., Arboe, B.
, Clausen, M. R., Jensen, P., Pedersen, M.
, Bukh, A., Jensen, B. A., Poulsen, C. B.
, D'Amore, F. & Hutchings, M. (2014).
Role of routine imaging in detecting recurrent lymphoma: A review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma.
American Journal of Hematology,
89(6), 575-580.
https://doi.org/10.1002/ajh.23688,
https://doi.org/10.1002/ajh.23688
D'Amore, F. A., Gaulard, P., Trümper, L., Corradini, P., Kim, W.-S., Specht, L.
& Pedersen, M. B. (2014).
T-cell lymphoma:L ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow up.
Annals of Oncology.
Coiffier, B., Federico, M., Caballero, D., Dearden, C., Morschhauser, F., Jäger, U., Trümper, L., Zucca, E., Gomes da Silva, M., Pettengell, R., Weidmann, E.
, d'Amore, F., Tilly, H. & Zinzani, P. L. (2014).
Therapeutic options in relapsed or refractory peripheral T-cell lymphoma.
Cancer Treatment Reviews,
40(9), 1080-1088.
https://doi.org/10.1016/j.ctrv.2014.08.001
Vase, M. Ø., Maksten, E. F.
, Bendix, K., Hamilton-Dutoit, S. J., Andersen, C., Møller, M. B., Sørensen, S. S.
, Jespersen, B., Kampmann, J., Rabinovich, G. A.
, Søndergaard, E., Nielsen, P. S. & D'Amore, F. A. (2014).
Tumor microenvironmental features and outcome in post-transplant lymphoproliferative disorder.
Blood,
124(21).
Vase, M. Ø., Maksten, E. F.
, Bendix, K., Hamilton-Dutoit, S. J., Andersen, C., Møller, M. B., Sørensen, S. S.
, Jespersen, B., Kampmann, J., Rabinovich, G. A.
, Søndergaard, E., Nielsen, P. S. & D'Amore, F. A. (2014).
Tumor microenvironmental features and outcome in post-transplant lymphoproliferative disorder. Poster session presented at ASH 2014 American Society of Hematology, San Francisco, United States.
Nielsen, R. B., Baumgartner-Nielsen, J., Peterslund, N. A., Steiniche, T., Bang, K.
, Deleuran, M. & D'Amore, F. A. (2013).
Alemtuzumab (ALZ) is an effective treatment for both primary and relapsed severe paraneoplastic pemphigus (PNP) associated to B-cell chronic lymphocytic leukemia.
British Journal of Dermatology,
169(2), 469-472.
Nielsen, R. B., Baumgartner-Nielsen, J., Peterslund, N. A., Steiniche, T., Deleuran, M. & D'Amore, F. A. (2013).
Alemtuzumab (alz) is effective against severe chronic lymphocytic leukemia-associated paraneoplastic pemphigus (pnp).
British Journal of Dermatology,
169(2).
Nielsen, R. B., Baumgartner-Nielsen, J., Peterslund, NA.
, Steiniche, T., Bang, K.
, Deleuran, M. & D'Amore, F. A. (2013).
Alemtuzumab (ALZ) is effective against severe paraneoplastic pemphigus (PNP).
British Journal of Dermatology.
Bech, M. R.
, Baumgartner-Nielsen, J., Peterslund, N. A., Steiniche, T., Deleuran, M. & d'Amore, F. (2013).
Alemtuzumab is effective against severe chronic lymphocytic leukaemia-associated paraneoplastic pemphigus.
British Journal of Dermatology,
169(2), 469-72.
https://doi.org/10.1111/bjd.12324
Vase, M. Ø., Friis, S., Bautz, A.
, Bendix, K., Sørensen, H. T. & d'Amore, F. (2013).
Breast implants and anaplastic large cell lymphoma: A Danish population-based cohort study.
Cancer Epidemiology, Biomarkers & Prevention,
22(11), 2126-2129.
https://doi.org/10.1158/1055-9965.EPI-13-0633
Ghielmini, M., Vitolo, U., Kimby, E., Montoto, S., Walewski, J., Pfreundschuh, M., Federico, M., Hoskin, P., McNamara, C. M., Caligaris-Cappio, F., Stilgenbauer, S., Marcus, R., Trneny, M., Dreger, P., Montserrat, E., Dreyling, M., Agostinelli, C., Arcaini, L., Campo, E. ... Zucca, E. (2013).
Esmo Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL) follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL).
Annals of Oncology,
24(3), 561-76.
Kucuk, C., Jiang, B., Hu, X., Gaulard, P., Zhang, W., Xiao, W., Staudt, LM., Iqbal, J., Cornish, A., Kavak, P., Alkan, C., Gong, Q., Yang, Q., Sun, H.
, D'Amore, F. A., Leppa, S., Liu, W., McKeithan, T. & Chan, WC. (2013).
Frequent activating mutations of JAK-Stat Pathway genes in natural killer cell lymphomas.
Blood.
Vase, M. Ø., Larsen, C. S., Bendix, K., Hamilton-Dutoit, S. J., Moeller, M. B.
& D'Amore, F. A. (2013).
Hiv-associated lymphoma in Western Denmark: Higher frequency of Burkitt histology and primary extranodal non-CNS presentation in the post-as compared to the pre-HAART ERA.
Hematological Oncology,
31, 216-217.
Snipsøyr, M. G., Wiggers, H., Knudsen, J. B., Ludvigsen, M., Poulsen, S. H., Petersen, E. & Honoré, B. (2013).
Identification of putative, novel biomarkers for infective endocarditis by proteomic analysis. Poster session presented at 30th annual meeting of Nordic Society of Clinical Microbiology and Infectious Diseases, Aarhus, Denmark.
El-Galaly, T. C., Hutchings, M., Mylam, K. J., de Nully Brown, P.
, Bukh, A., Johnsen, H. E., Kamper, P., Loft, A.
, Iyer, V., Gormsen, L. C., Nielsen, A. L., Bøgsted, M. & d'Amore, F. (2013).
Impact of 18F-FDG PET/CT Staging in Newly Diagnosed Classical Hodgkin Lymphoma: Less Cases with Stage I Disease and More with Skeletal Involvement.
Leukemia & Lymphoma.
https://doi.org/10.3109/10428194.2013.875169
Wästerlid, T., Brown, P. D. N., Hagberg, O., Hagberg, H., Pedersen, LM.
, D'Amore, F. A. & Jerkeman, M. (2013).
Impact of chemotherapy regimen and rituximab in adult Burkitt Lymphoma: a retrospective population-based study from the Nordic Lymphoma Group.
Annals of Oncology,
24(7), 1879-1886.
D'Amore, F. A., Lauritzsen, G. F., Relander, T., Jantunen, E., Hagberg, H., Anderson, H., Holte, H., Osterborg, A., Merup, M., Brown, P., Kuittinen, O., Erlanson, M., Ostenstad, B., Fagerli, U., Gadeberg, O., Sundstrom, C., Delabie, J., Ralfkiaer, E., Vornanen, M.
& Toldbod, H. (2013).
Late relapses in peripheral T-cell lymphoma patients treated in the nordic NLG-T-01 trial.
Hematological Oncology,
31, 176-177.
Vase, M. Ø., S, E. F.
, Bendix, K., Jespersen, B., Hamilton-Dutoit, S. J., Schwartz, S., Andersen, C.
& D'Amore, F. A. (2013).
Monomorphic PTLD in a danish cohort: HLA tissue subtype matching correlates with survival.
Hematological Oncology,
31, 216.
El-Galaly, T. C., Mylam, K., Brown, P., Rossing, M., Gang, A., Haglund, A., Arboe, B., Clausen, M., Jensen, P., Pedersen, M.
, Bukh, A., Amdi Jensen, B., Poulsen, C.
, D'Amore, F. A. & Hutchings, M. (2013).
Patient-reported symptoms are still the single most important factor for detecting lymphoma relapse.
Hematological Oncology,
31.
Ludvigsen, M., Madsen, C.
, Kamper, P., Hamilton-Dutoit, S. J., Bendix, K., D'Amore, F. A. & Honoré, B. (2013).
Proteomic analysis identifies differential expression patterns in follicular lymphoma patients with or without subsequent histological transformation.
Hematological Oncology,
31, 203.
Ludvigsen, M., Pedersen, M. B., Hamilton-Dutoit, S. J., Bendix, K., Moeller, M. B., Noergaard, P.
, D'Amore, F. A. & Honoré, B. (2013).
Proteomic analysis identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specified. Hematological Oncology,
31, 174-175.
Gang, AO., Pedersen, M.
, D'Amore, F. A., Pedersen, LM.
, Bukh, A., Pedersen, BB., Moeller, MB., Mourits-Andersen, T.
, Pulczynski, S. & Brown, P. D. N. (2013).
R-CHOEP-14 improves overall survival in young high-risk patients with diffuse large B-cell lymphoma compared with R-CHOP-14. An updated analysis with 5 years median follow-up of the population-based investigation from the Danish Lymphoma Group.
Hematological Oncology (Online),
31(suppl 1), 167-168.
https://doi.org/10.1002/hon.2058
Johnson, P., Federico, M., Fossa, A., O'Doherty, M., Roberts, T., Stevens, L., Smith, P., Kirkwood, A., Anghe, G., Trotman, J., Berkahn, L.
, D'Amore, F. A., Enblad, G., Luminari, S., Viney, Z., Radford, J. & Barrington, S. (2013).
Responses and chemotherapy dose adjustment determined by PET-CT imaging: First results from the international response adapted therapy in advanced hodgkin lymphoma (RATHL) study.
Hematological Oncology,
31, 138.